Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/10/25
End: 04/16/25
Due: 04/16/26
Phase: N/A
Priority: Normal
Start: 02/10/25
End: 03/25/25
Due: 03/25/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy Subjects | NCT06528665 | Corium Innovations, Inc. | user2@example.com | None | 2025-02-10 | 2025-04-16 | 2026-04-16 | - | - | 2025-07-14 |
| Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects | NCT06607744 | Corium Innovations, Inc. | user2@example.com | None | 2025-02-10 | 2025-03-25 | 2026-03-25 | - | - | 2025-07-14 |